Management of Linzess with GoLYTELY Bowel Preparation
Discontinue Linzess (linaclotide) 72 mg at least 24 hours before starting GoLYTELY bowel preparation, as the FDA label explicitly states not to take other laxatives while taking GoLYTELY. 1
Rationale and Timing
The GoLYTELY FDA label provides clear guidance that patients should not take other laxatives while taking GoLYTELY 1. Since Linzess is a guanylate cyclase-C agonist that increases intestinal fluid secretion and accelerates GI transit 2, combining it with the osmotic purgative effects of GoLYTELY could theoretically increase the risk of:
- Excessive fluid and electrolyte losses
- Severe diarrhea
- Dehydration
- Electrolyte disturbances that can lead to cardiac arrhythmias or seizures 1
Specific Discontinuation Protocol
Stop Linzess 72 mg the day before you begin GoLYTELY preparation. For example:
- If colonoscopy is scheduled for Wednesday morning
- Stop Linzess on Monday (your last regular dose)
- Begin GoLYTELY on Tuesday evening per split-dose protocol 3
GoLYTELY Administration Guidelines
According to the 2025 US Multi-Society Task Force guidelines and FDA labeling:
For morning colonoscopies (preferred approach):
- Begin GoLYTELY early evening the day before
- Use split-dose regimen: consume half the evening before, complete the second half 4-6 hours before colonoscopy
- Finish at least 2 hours before procedure start 3, 1
For afternoon colonoscopies:
- Same-day dosing is an acceptable alternative to split-dosing 3
Important Safety Considerations
The GoLYTELY label emphasizes several critical precautions 1:
- Correct any fluid and electrolyte abnormalities BEFORE starting GoLYTELY
- Do not take oral medications within 1 hour before or during GoLYTELY administration
- Hydrate adequately before, during, and after use
- If severe bloating, distention, or abdominal pain occurs, slow or temporarily discontinue until symptoms resolve
When to Resume Linzess
Resume Linzess after the colonoscopy is completed and you have returned to normal eating. Typically this means waiting until the day after your procedure, once you've tolerated solid food and your bowel function is returning to baseline.
Context from Recent Research
While recent meta-analyses suggest that adding linaclotide to PEG-based preparations may improve bowel cleansing quality and reduce adverse symptoms 4, 5, 6, these studies used single-dose linaclotide (typically 290 mcg) given 1-2 days before colonoscopy as an adjunct—not continuation of chronic daily therapy during the prep. The FDA label prohibition against concurrent laxatives takes precedence over investigational protocols 1.
Common Pitfall to Avoid
Do not assume that because linaclotide is used for constipation, continuing it will improve your prep. The FDA-approved GoLYTELY regimen is designed as a complete bowel preparation system, and adding other laxatives increases risk without established benefit in the context of chronic daily use. The research showing benefit used linaclotide as a planned adjunct in specific protocols, not as continuation of baseline therapy 4, 5.